{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:58:13Z","timestamp":1786982293830,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Advanced Suitable Technology Popularization Project of Shanghai Health System","award":["2013SY073"],"award-info":[{"award-number":["2013SY073"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12185-018-02582-x","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T21:54:32Z","timestamp":1546466072000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical features of dyskeratosis congenita in mainland China: case reports and literature review"],"prefix":"10.1007","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-8452","authenticated-orcid":false,"given":"Fuxing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"key":"2582_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12308-011-0089-5","volume":"4","author":"I Dokal","year":"2011","unstructured":"Dokal I, Vulliamy T. Inherited bone marrow failure syndromes. J Hematop. 2011;4:53\u201360.","journal-title":"J Hematop"},{"key":"2582_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1399-3046.2007.00721.x","volume":"11","author":"JDL Fuente","year":"2007","unstructured":"Fuente JDL, Dokal I. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr Transplant. 2007;11:584\u201394.","journal-title":"Pediatr Transplant"},{"key":"2582_CR3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1542\/peds.67.6.898","volume":"7","author":"BK De","year":"1981","unstructured":"De BK, Degreef H, Verwilghen R, Corbeel L, Casteels Van DM. Thrombocytopenia: first symptom in a patient with dyskeratosis congenita. Pediatrics. 1981;7:898\u2013903.","journal-title":"Pediatrics"},{"key":"2582_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ejhg.2011.90","volume":"19","author":"I Dokal","year":"2011","unstructured":"Dokal I, Vulliamy T, Mason P, Bessler M. Clinical utility gene card for: dyskeratosis congenita. Eur J Hum Genet. 2011;19:1\u201311.","journal-title":"Eur J Hum Genet"},{"key":"2582_CR5","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","volume":"113","author":"BP Alter","year":"2009","unstructured":"Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009;113:6549\u201357.","journal-title":"Blood"},{"key":"2582_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2141.2009.07598.x","volume":"145","author":"AJ Walne","year":"2009","unstructured":"Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. Br J Haematol. 2009;145:164\u201372.","journal-title":"Br J Haematol"},{"key":"2582_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12185-010-0695-5","volume":"92","author":"N Nishio","year":"2010","unstructured":"Nishio N, Kojima S. Recent progress in dyskeratosis congenita. Int J Hematol. 2010;92:419\u201324.","journal-title":"Int J Hematol"},{"key":"2582_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187\u2013207.","journal-title":"Br J Haematol"},{"key":"2582_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","volume":"24","author":"A Shimamura","year":"2010","unstructured":"Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24:101\u201322.","journal-title":"Blood Rev"},{"key":"2582_CR10","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1046\/j.1365-2141.1998.01103.x","volume":"103","author":"S Knight","year":"2015","unstructured":"Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I. Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol. 2015;103:990\u20136.","journal-title":"Br J Haematol"},{"key":"2582_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1182\/asheducation-2011.1.480","volume":"2011","author":"I Doka","year":"2011","unstructured":"Doka I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program. 2011; 2011:480\u20136.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2582_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1586\/ehm.13.23","volume":"6","author":"BJ Ballew","year":"2013","unstructured":"Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2013;6(3):327\u201337.","journal-title":"Expert Rev Hematol"},{"key":"2582_CR13","first-page":"212","volume":"23","author":"JY Zhang","year":"2015","unstructured":"Zhang JY, An WB, Zhang L, Chang LX, Qi BQ, Liu TF, et al. Genotype analysis and telomere length measure in patients with dyskeratosis congenita. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015;23:212\u20136.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"2582_CR14","first-page":"157","volume":"35","author":"X Liu","year":"2012","unstructured":"Liu X, Li XY, Deng WP, Dong X, Zhang QLX, Hu ZZ. Telomere length in patients with dyskeratosis congenita in a Chinese Family. Int J Genet. 2012;35:157\u201360.","journal-title":"Int J Genet"},{"key":"2582_CR15","first-page":"407","volume":"22","author":"A Zhou","year":"2001","unstructured":"Zhou A, Xia XX, Chen Z, Li FZL, Liang XS. Bone marrow transplantation in the treatment of two cases of dyskeratosis congenita. Zhonghua Xue Ye Xue Za Zhi. 2001;22:407.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"2582_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/bmj.2.6200.1305","volume":"2","author":"J Appleyard","year":"1979","unstructured":"Appleyard J, Maden JG. Multidisciplinary teams. Br Med J. 1979;2:1305\u20137.","journal-title":"Br Med J"},{"key":"2582_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/pbc.22061","volume":"53","author":"SA Savage","year":"2009","unstructured":"Savage SA, Dokal I, Armanios M, Aubert G, Cowen EW, Domingo DL, et al. Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer. 2009;53:520\u20133.","journal-title":"Pediatr Blood Cancer"},{"key":"2582_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","volume":"23","author":"SA Savage","year":"2009","unstructured":"Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clin N Am. 2009;23:215\u201331.","journal-title":"Hematol Oncol Clin N Am"},{"key":"2582_CR19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","volume":"110","author":"I Dokal","year":"2000","unstructured":"Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768\u201379.","journal-title":"Br J Haematol"},{"key":"2582_CR20","first-page":"56","volume":"15","author":"S Kumar","year":"2013","unstructured":"Kumar S, Suthar R. Dyskeratosis Congenita. Br J Oral Surg. 2013;15:56\u20138.","journal-title":"Br J Oral Surg"},{"key":"2582_CR21","first-page":"410","volume":"4","author":"A Dean","year":"1999","unstructured":"Dean A, Alamillos FJ, Velez A, Velasco F, Rodas J, Garcia A. Squamous cell carcinoma of the oral cavity and Fanconi\u2019s anemia. An association to bear in mind. Med Oral. 1999;4:410\u20135.","journal-title":"Med Oral"},{"key":"2582_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/MOH.0b013e3282fa7470","volume":"15","author":"NS Young","year":"2008","unstructured":"Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin hematol. 2008;15:162\u20138.","journal-title":"Curr Opin hematol"},{"key":"2582_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/TACG.S58444","volume":"7","author":"D Buchbinder","year":"2014","unstructured":"Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott\u2013Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55\u201366.","journal-title":"Appl Clin Genet"},{"issue":"default","key":"2582_CR24","first-page":"157","volume":"2014","author":"MS Fern\u00e1ndez Garc\u00eda","year":"2014","unstructured":"Fern\u00e1ndez Garc\u00eda MS, Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med. 2014; 2014(default):157\u201367.","journal-title":"J Blood Med."},{"key":"2582_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/MOH.0000000000000290","volume":"23","author":"S Elmahadi","year":"2016","unstructured":"Elmahadi S, Muramatsu H, Kojima S. Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita. Curr Opin Hematol. 2016;23:501\u20137.","journal-title":"Curr Opin Hematol"},{"key":"2582_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/bjh.12748","volume":"165","author":"PP Khincha","year":"2014","unstructured":"Khincha PP, Wentzensen IM, Giri N, Alter BP, Savage SA. Response to androgen therapy in patients with dyskeratosis congenita. Br J Haematol. 2014;165:349\u201357.","journal-title":"Br J Haematol"},{"key":"2582_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.hoc.2018.04.003","volume":"32","author":"S Agarwal","year":"2018","unstructured":"Agarwal S. Evaluation and management of hematopoietic failure in dyskeratosis congenita. Hematol Oncol Clin N Am. 2018;32:669\u201385.","journal-title":"Hematol Oncol Clin N Am"},{"key":"2582_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2141.2008.07516.x","volume":"144","author":"M Kirwan","year":"2009","unstructured":"Kirwan M, Beswick R, Yulliamy T, Nathwani AC, Walne AJ, Casimir C. Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. Br J Haematol. 2009;144:771\u201381.","journal-title":"Br J Haematol"},{"key":"2582_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbadis.2009.01.010","volume":"1792","author":"M Kirwan","year":"2009","unstructured":"Kirwan M, Doka I. Dyskeratosis congenita, stem cell and telomeres. Biochim Biophys Acta. 2009;1792:371\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"2582_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/GIM.0b013e3181f415b5","volume":"12","author":"SA Savage","year":"2010","unstructured":"Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere, biology disorders. Genet Med. 2010;12:753\u201364.","journal-title":"Genet Med"},{"key":"2582_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cancergen.2011.11.002","volume":"204","author":"PJ Mason","year":"2011","unstructured":"Mason PJ, Bessler M. The genetics of dyskeratosis congenita. Cancer Genet. 2011;204:635\u201345.","journal-title":"Cancer Genet"},{"key":"2582_CR32","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s12185-015-1861-6","volume":"102","author":"H Yamaguchi","year":"2015","unstructured":"Yamaguchi H, Sakaguchi H, Yoshida K, Yabe M, Yabe H, Okuno Y, et al. Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan. Int J Hematol. 2015;102:544\u201352.","journal-title":"Int J Hematol"},{"key":"2582_CR33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/ajh.24545","volume":"91","author":"J Xu","year":"2016","unstructured":"Xu J, Khincha PP, Giri N, Alter BP, Savage SA, Wong JM. Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations. Am J Hematol. 2016;91:1215\u201320.","journal-title":"Am J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-02582-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-02582-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-02582-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T12:21:26Z","timestamp":1662726086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-02582-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-02582-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}